Heineman H S, Lofton W M
Antimicrob Agents Chemother. 1978 May;13(5):827-31. doi: 10.1128/AAC.13.5.827.
The combined activity of ticarcillin and each of three aminoglycosides, gentamicin, tobramycin, and amikacin, was studied with 45 clinical isolates of Pseudomonas aeruginosa. All strains individually were susceptible to each of these agents. Comparison of the results revealed highly variable interaction, both from strain to strain and from one aminoglycoside to another against the same strain. Against 11 strains, none of three antibiotic pairs tested was synergistic by conventional criteria; against the remaining 34, three, any two, or any one pair among those tested was synergistic. The minimal inhibitory concentrations of individual drugs gave no indication of the degree of synergism to be expected. We conclude that generalizations about the behavior of this organism vis-à-vis penicillin-aminoglycoside combinations in vitro are subject to many exceptions. Furthermore, no test using a particular antibiotic combination is reliable as a screen for other combinations. If this experience is duplicated in vivo, combination testing may be as important for the choice of combination therapy as individual susceptibility testing is for the choice of individual antibiotics.
用45株铜绿假单胞菌临床分离株研究了替卡西林与三种氨基糖苷类药物(庆大霉素、妥布霉素和阿米卡星)联合使用的活性。所有菌株对这些药物均敏感。结果比较显示,菌株之间以及同一菌株对不同氨基糖苷类药物的相互作用差异很大。按照传统标准,在11株菌株中,所测试的三对抗生素均无协同作用;在其余34株中,所测试的三对、任意两对或任意一对具有协同作用。单一药物的最低抑菌浓度无法表明预期的协同程度。我们得出结论,关于该生物体在体外对青霉素 - 氨基糖苷类药物组合反应的一般结论存在许多例外情况。此外,使用特定抗生素组合的测试不能可靠地筛选其他组合。如果体内实验也得到相同结果,那么联合用药测试对于联合治疗方案的选择可能与个体药敏测试对于个体抗生素的选择同样重要。